An observational study in Irvine Gass Syndrome, sponsored by Medical University of Vienna. Completed at 1 site in Austria. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2015-09-24.
Sponsored by Medical University of Vienna · Observational
Purpose: To evaluate morphological and functional characteristics of Irvine Gass syndrome
Methods: 30 patients suffering on Cystoid macular edema (CME) secondary to Cataract surgery will be observed and evaluated by fluorescein-angiography, SD-OCT, reading performance, contrast sensitivity and microperimetry in a fixed time schedule
841 studies on the registry are indexed under Macular Edema; 56 are open to participants now.
This study's enrollment of 50 is below the median of 97 across 163 observational studies indexed under Macular Edema.
Browse Macular Edema studies →Medical University of Vienna is the lead sponsor of 1,076 studies on the registry; 177 are open to participants now.
Counted across the registry records on this site, refreshed daily.
30 patients suffering on CME secondary to cataract surgery
Exclusion Criteria:
Behavioral: if needed (decided individually) either Acular eye drops, Ultracortenol eye drop or intravitreal triamcinolone injection
if prescribed: Ultracortenol/ Acular eye drops 3-4 times a day, if prescribed: singular intravitreal triamcinolone injection
Reduction of central retinal thickness
Time frame: 3 months
Increase of Best corrected visual acuity
Time frame: 3 months
This study is completed, as verified in Sep 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical University of Vienna